Figure 3
Figure 3. Mature DCs in murine lymph nodes are more susceptible to glucocorticoid killing than immature DCs during experimental asthma. (A) Triple immunostaining of CD11c (green), MHC II (red), and caspase 3 (blue) was performed on mediastinal lymph node sections as described in “Methods” and in Figure 1. Merged images contain staining for all 3 antigens and show that the majority of the caspase 3+ cells (red arrows) are mature DCs. Scale bar, 20 μm. (B) OVA treatment increased the number of DCs (± SD) in mediastinal lymph nodes. Approximately 150 (CON and DEX groups) to 900 (OVA and OVA+DEX) cells per animal (n = 6 per group) were counted across 3 to 12 sections. (C) DEX induced caspase 3 activation more efficiently in mature DCs than in immature DCs (*significantly greater than CON, P < .01; 1-way ANOVA followed by Tukey posthoc test).

Mature DCs in murine lymph nodes are more susceptible to glucocorticoid killing than immature DCs during experimental asthma. (A) Triple immunostaining of CD11c (green), MHC II (red), and caspase 3 (blue) was performed on mediastinal lymph node sections as described in “Methods” and in Figure 1. Merged images contain staining for all 3 antigens and show that the majority of the caspase 3+ cells (red arrows) are mature DCs. Scale bar, 20 μm. (B) OVA treatment increased the number of DCs (± SD) in mediastinal lymph nodes. Approximately 150 (CON and DEX groups) to 900 (OVA and OVA+DEX) cells per animal (n = 6 per group) were counted across 3 to 12 sections. (C) DEX induced caspase 3 activation more efficiently in mature DCs than in immature DCs (*significantly greater than CON, P < .01; 1-way ANOVA followed by Tukey posthoc test).

Close Modal

or Create an Account

Close Modal
Close Modal